INDICATION & LIMITATION OF USE

DESCOVY® for HIV-1 pre-exposure prophylaxis (PrEP) is indicated in at-risk adults and adolescents (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection, excluding individuals at risk from receptive vaginal sex. HIV-1–negative status must be confirmed immediately prior to initiation.

Limitation of Use: DESCOVY FOR PrEP® is not indicated in individuals at risk of HIV-1 from receptive vaginal sex because effectiveness in this population has not been evaluated.

Please see below for Important Safety Information for DESCOVY.

Helpful videos and resources

Hear from experts on the role PrEP plays in communities most vulnerable and affected by HIV

Click to learn about the impact of PrEP (pre-exposure prophylaxis) on new HIV diagnoses.

Impact of PrEP on New HIV Diagnoses

Learn more about the impact of PrEP on new HIV diagnoses.

Click to learn about PrEP (pre-exposure prophylaxis) Use in the Black Community.

PrEP Use in the Black Community

Learn more about reframing HIV prevention and emphasizing its importance to sexual health in the Black community.

Click to learn about PrEP (pre-exposure prophylaxis) Use in the Latinx/o Community.

PrEP Use in the Latinx/o Community

Learn more about helping to address barriers to PrEP uptake in the Latinx/o community.

Click to learn about PrEP (pre-exposure prophylaxis) Use in Young MSM.

PrEP Use in Young MSM

Learn more about engaging and educating young men on HIV prevention.

Resources and tools for healthcare professionals

Below, you can find a variety of digital and downloadable resources designed with information about DESCOVY FOR PrEP® for you and the appropriate individuals you see.

CPT=Current Procedural Terminology; HCP=healthcare professional; ICD-10-CM=International Classification of Diseases, Tenth Revision, Clinical Modification; MSM=men who have sex with men; STI=sexually transmitted infection; TAF=tenofovir alafenamide.